Lihong Shi
- Molecular Biology top 5%
- Oncology top 2%
- Cancer Research top 2%
- Endocrinology, Diabetes and Metabolism top 2%
- Organic Chemistry top 5%
- Co-authors
- Marc NavreMichael B. WallaceDaniel B. KasselBaogang ZhangJeffrey A. StaffordHongli LiKoji TakeuchiMatthew M. Smith
- Topics
- Peptidase Inhibition and Analysis (17 papers)MicroRNA in disease regulation (12 papers)Epigenetics and DNA Methylation (12 papers)
- Journals
- Journal of Biological ChemistrySHILAP Revista de lepidopterologíaBlood
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Lihong Shi
116 papers receiving 3.4k citations
Peers
Comparison fields: 5 of 137
- Molecular Biology 1.7k
- Oncology 1.0k
- Cancer Research 658
- Endocrinology, Diabetes and Metabolism 478
- Organic Chemistry 395
Countries citing papers authored by Lihong Shi
This map shows the geographic impact of Lihong Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lihong Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lihong Shi more than expected).
Fields of papers citing papers by Lihong Shi
This network shows the impact of papers produced by Lihong Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lihong Shi. The network helps show where Lihong Shi may publish in the future.
Co-authorship network of co-authors of Lihong Shi
This figure shows the co-authorship network connecting the top 25 collaborators of Lihong Shi. A scholar is included among the top collaborators of Lihong Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lihong Shi. Lihong Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 8 | |
| 3 | 19 | |
| 4 | 15 | |
| 5 | 40 | |
| 6 | 3 | |
| 7 | 3 | |
| 8 | 16 | |
| 9 | 12 | |
| 10 | 43 | |
| 11 | 17 | |
| 12 | 21 | |
| 13 | 90 | |
| 14 | 34 | |
| 15 | 55 | |
| 16 | 21 | |
| 17 | 15 | |
| 18 | 93 | |
| 19 | 11 | |
| 20 | 26 |
About Lihong Shi
Lihong Shi is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 118 papers that have together received 3.5k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (17 papers), MicroRNA in disease regulation (12 papers) and Epigenetics and DNA Methylation (12 papers). The work is most often cited by research in Cancer Research (658 citations), Oncology (1.0k citations) and Endocrinology, Diabetes and Metabolism (478 citations). Lihong Shi has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Marc Navre, Michael B. Wallace, Daniel B. Kassel, Baogang Zhang, Jeffrey A. Stafford, Hongli Li, Koji Takeuchi, Matthew M. Smith, Stephen L. Gwaltney and R.J. Skene. Their work appears in journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.